2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1578616520 M.D.
Verify on CMS →

NADEEM VAIDYA, M.D.

Retina Specialist (Ophthalmology) Physician in IRVINE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
186
Medicare Part D claims · 65 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75.25/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$687.49
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NADEEM VAIDYA, M.D. reported a CMS MIPS final score of 75.25/100 — below the 83.1 national average — and filed 186 Medicare Part D claims in 2023.

75.25/100
MIPS score · -8 vs avg
186
Part D claims, 2023
66%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NADEEM VAIDYA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NADEEM VAIDYA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NADEEM VAIDYA, M.D.?

Below national average

NPI registry status

Active

Issued 01/20/2007

NPI 1578616520

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

186 67% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

75.25/100 7.849999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Retina Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers

Retina Specialist (Ophthalmology) Physician share within California

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within California

Medicare quality performance — MIPS

NADEEM VAIDYA, M.D.'s 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

Below national average
MIPS Final Score
75.25/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 75.25/100 vs national avg 83.1

0%100%National avg83%75.3%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 75.25/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NADEEM VAIDYA, M.D. appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding M.D. credentials at 16100 SAND CANYON AVE STE 385, IRVINE, CA, 92618, with a listed phone of (949) 732-0201. NPI 1578616520 was issued on 01/20/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VAIDYA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 186 prescription claims written by this provider, covering 65 Medicare beneficiaries and totaling roughly $15K in drug spend, split 34% brand-name and 66% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75.25/100 for the 2023 performance year (Quality 55), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

16100 SAND CANYON AVE STE 385
IRVINE, CA 92618

Provider Details

NPI 1578616520
Specialty Retina Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Male
NPI Issued 01/20/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75.25
Final Score
Avg: 83.1
55
Quality
100
Promoting Interoperability

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NADEEM VAIDYA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$687

Largest payer

Genentech USA, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to NADEEM VAIDYA, M.D.. To verify NADEEM VAIDYA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

NADEEM VAIDYA, M.D. — brand share 34.0%
Specialty average (est.)

34% brand-name claims vs 66% generic, on 186 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

186
Total Claims
$15K
Total Drug Cost
65
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
298
Total Day Supply
8,205
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$11K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
1.45
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What NADEEM VAIDYA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
51
Ketorolac Tromethamine
36
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
28
Ofloxacin
17
Brimonidine Tartrate
11
Latanoprost
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How NADEEM VAIDYA, M.D. fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

NADEEM VAIDYA, M.D.'s 186 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as VAIDYA.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NADEEM VAIDYA, M.D.'s specialty?
NADEEM VAIDYA, M.D. specializes in Retina Specialist (Ophthalmology) Physician and practices in IRVINE, California. Credentials: M.D..
How much does NADEEM VAIDYA, M.D. prescribe under Medicare Part D?
In 2023, NADEEM VAIDYA, M.D. wrote 186 Medicare Part D claims totaling $15K in drug costs for 65 beneficiaries.
What is NADEEM VAIDYA, M.D.'s Medicare quality score?
NADEEM VAIDYA, M.D. has a CMS MIPS Final Score of 75.25/100 (Quality: 55). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NADEEM VAIDYA, M.D. located?
NADEEM VAIDYA, M.D. is located at 16100 SAND CANYON AVE STE 385, IRVINE, CA, 92618. Phone: (949) 732-0201.
What is NADEEM VAIDYA, M.D.'s NPI number?
NADEEM VAIDYA, M.D.'s National Provider Identifier (NPI) is 1578616520, issued on 01/20/2007.
Does NADEEM VAIDYA, M.D. prescribe more brand-name or generic drugs?
NADEEM VAIDYA, M.D.'s prescribing is 34% brand-name and 66% generic drugs by claim count, with $11K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does NADEEM VAIDYA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, NADEEM VAIDYA, M.D.'s most frequently prescribed drugs include Prednisolone Acetate, Ketorolac Tromethamine, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NADEEM VAIDYA, M.D. accept Medicare?
NADEEM VAIDYA, M.D. appears in CMS Medicare data with 186 Part D claims and 65 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NADEEM VAIDYA, M.D.'s credentials?
NADEEM VAIDYA, M.D.'s NPI is 1578616520 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology